[On the therapy of metastases of uterine adenocarcinoma].
D000230:Adenocarcinoma / Q000532:radiotherapy* / Q000601:surgery; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D006908:Hydroxyprogesterones / Q000627:therapeutic use*; D007044:Hysterectomy; D008175:Lung Neoplasms / Q000188:drug therapy*; D008875:Middle Aged; D009362:Neoplasm Metastasis / Q000188:drug therapy*; D011183:Postoperative Complications; D011883:Radium / Q000627:therapeutic use*; D014228:Triaziquone / Q000627:therapeutic use*; D014594:Uterine Neoplasms / Q000532:radiotherapy* / Q000601:surgery
D000970:Antineoplastic Agents; D006908:Hydroxyprogesterones; D014228:Triaziquone; D011883:Radium
Contributo alla terapia delle metastasi da adenocarcinoma uterino.